DavidPMcLaughlinMDFACC
Cardiology • Harrisonburg, VAAdult Congenital Heart Disease, Cardiac Electrophysiology, Interventional Cardiology
Director Cardiac Cath Lab and Intervention Sentera RMH medical center
Dr. McLaughlin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2006 Health Campus Dr
Harrisonburg, VA 22801Phone+1 540-689-7400Fax+1 757-963-9617
Education & Training
University of North Carolina HospitalsFellowship, Interventional Cardiology, 2004 - 2005
University of Virginia Medical CenterFellowship, Cardiovascular Disease, 1990 - 1993
Drexel University College of Medicine/Hahnemann University HospitalResidency, Internal Medicine, 1986 - 1990
Pennsylvania State University College of MedicineClass of 1986
Certifications & Licensure
VA State Medical License 1990 - 2026
ID State Medical License 2006 - 2007
MT State Medical License 2005 - 2007
NC State Medical License 2004 - 2006
PA State Medical License 1987 - 1990- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- 2 citationsThe contrast media iohexol causes vasoconstriction of the proximal left anterior descending coronary artery: implications for appropriate stent sizing.Robert V. Kelly, Michael Gillespie, Mauricio G. Cohen, David P. McLaughlin, E. Magnus Ohman
Angiology. 2008-05-27 - 1 citationsRenal Fibromuscular DysplasiaDavid P. McLaughlin, Robert V. Kelly, R. A. Santa-Cruz, George A. Stouffer
Circulation. 2005-10-25 - 13 citationsHemodynamic and metabolic correlates of dipyridamole-induced myocardial thallium-201 perfusion abnormalities in multivessel coronary artery diseaseDavid P. McLaughlin, George A. Beller, Joel Linden, Carlos R. Ayers, Marcia L. Ripley
The American Journal of Cardiology. 1994-06-15
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
